Limerick East): No legal indemnities have been provided for the National Drugs Advisory Board for any claims against it in relation to drugs it has licensed in human or animal medicines. However, section 5 of the Control of Clinical Trials and Drugs Act, 1990, provides that no action or other proceeding shall lie or be maintainable, except in the case of wilful neglect or default, against the National Drugs Advisory Board for the recovery of damages in respect of any injury to persons or property alleged to have been caused or contributed to by reason of or arising from the discharge of any of their functions imposed by or under the Control of Clinical Trials Acts, 1987 and 1990, or Article 4 of the National Drugs Advisory Board (Establishment) Order, 1966. These provisions have been transferred to the Irish Medicines Board which was established on 1 January 1996 to take over the functions of the National Drugs Advisory Board.